|
Volumn 16, Issue 88, 2007, Pages 80-86
|
A look back at pharmaceuticals in 2006: Aggressive advertising cannot hide the absence of therapeutic advances
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA2B INTERFERON;
ANTIDEPRESSANT AGENT;
BEVACIZUMAB;
BICALUTAMIDE;
BUFLOMEDIL;
CARBIDOPA;
CYTOTOXIC AGENT;
DESMOPRESSIN;
EFLORNITHINE;
FLURBIPROFEN;
GENERIC DRUG;
HUMAN INSULIN;
IBUPROFEN;
ILOPROST;
LEVODOPA;
METFORMIN;
MORPHINE;
NAVELBINE;
NICOTINIC ACID;
NITISINONE;
PEGAPTANIB;
PRAMIPEXOLE;
RIBAVIRIN;
RIMONABANT;
ROPINIROLE;
SILDENAFIL;
TESTOSTERONE;
TRICLABENDAZOLE;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
UNINDEXED DRUG;
ARTICLE;
BREAST CANCER;
CARDIOTOXICITY;
CARDIOVASCULAR DISEASE;
CHILD HEALTH CARE;
COLORECTAL CANCER;
CONTRACEPTION;
DEPRESSION;
DRUG APPROVAL;
DRUG CONTRAINDICATION;
DRUG DOSAGE FORM COMPARISON;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG INFORMATION;
DRUG MARKETING;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
DRUG WITHDRAWAL;
ENURESIS;
EVIDENCE BASED MEDICINE;
FASCIOLIASIS;
GOVERNMENT REGULATION;
HIRSUTISM;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
LOW DRUG DOSE;
LUNG DISEASE;
METABOLIC SYNDROME X;
NEUROLOGIC DISEASE;
POSTTRAUMATIC STRESS DISORDER;
PREGNANCY;
PROSTATE CANCER;
PULMONARY HYPERTENSION;
RESTLESS LEGS SYNDROME;
RETINA MACULA DEGENERATION;
RHEUMATIC DISEASE;
RISK BENEFIT ANALYSIS;
SORE THROAT;
UNSPECIFIED SIDE EFFECT;
|
EID: 34547921678
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (0)
|